GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Computer-Aided Detection (CADe) in Routine Colonoscopy: Gastroenterology | July 2026

Computer-Aided Detection (CADe) in Routine Colonoscopy: Gastroenterology | July 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated July 1, 2026

Quick Answer

Introduction: Adenoma detection rate (ADR) is the most important quality indicator for colonoscopy and is directly associated with reduced colorectal cancer risk. Although randomized trials have shown that artificial intelligence–based computer-aided detection (CADe) improves ADR, its effectiveness in routine clinical practice has remained uncertain.


Introduction:

Adenoma detection rate (ADR) is the most important quality indicator for colonoscopy and is directly associated with reduced colorectal cancer risk. Although randomized trials have shown that artificial intelligence–based computer-aided detection (CADe) improves ADR, its effectiveness in routine clinical practice has remained uncertain. This large real-world quality improvement study evaluated the impact of CADe implementation across the Veterans Health Administration.

Why was this study needed?

  • Randomized trials have shown improved ADR with CADe, but real-world evidence has been inconsistent.
  • The effectiveness of CADe across different endoscopist experience levels remained unclear.
  • Quality improvement data are needed before widespread implementation.
  • Increasing ADR is a proven strategy for colorectal cancer prevention.
  • AI-assisted colonoscopy is rapidly entering routine clinical practice.

Results:

  • Implementation of CADe significantly increased adenoma detection rates, with a 22% higher likelihood of detecting at least one adenoma compared with standard colonoscopy.
  • The benefit was consistent across all endoscopists, including those who already had high baseline adenoma detection rates.
  • CADe did not increase unnecessary biopsies, prolong withdrawal time, or alter colorectal cancer detection, supporting its efficient integration into routine practice.

Clinical Impact:

This large real-world study confirms that AI-assisted colonoscopy improves adenoma detection outside clinical trials and benefits both average and high-performing endoscopists. These findings support broader implementation of CADe as a quality improvement tool to enhance colorectal cancer prevention.

Bottom Line:

Computer-aided detection (CADe) improves adenoma detection in everyday clinical practice regardless of baseline endoscopist performance. AI is becoming an effective quality-enhancement tool that complements, rather than replaces, the expertise of the endoscopist.

Related Q&A

Randomized Comparison of Endoscopic Gastroplasty Techniques for Obesity: Clinical Gastrointestinal Endoscopy | July 2026

Introduction: Endoscopic gastroplasty has emerged as an effective minimally invasive treatment for obesity, offering an alternative to bariatric surgery. Multiple endoscopic techniques are currently available, but comparative evidence has been limited. This randomized pragmatic trial...

Low-Volume PEG for Inpatient Colonoscopy: Annals of Internal Medicine | July 2026

Introduction: Adequate bowel preparation is often difficult to achieve in hospitalized patients because of advanced age, comorbidities, immobility, and concurrent medications. This multicenter randomized INTERPRET trial compared 1-L, 2-L, and 4-L polyethylene glycol (PEG) regimens...

Cold vs Hot Snare Polypectomy for Pedunculated Colorectal Polyps: Endoscopy | July 2026

A randomized controlled trial published in Endoscopy (July 2026) compared cold snare polypectomy (CSP) with hot snare polypectomy (HSP) for small pedunculated colorectal polyps. ### Key findings - **CSP eliminated delayed post-polypectomy bleeding (DPPB)** and...

Novel Catheter Improves Endoscopic Transpapillary Gallbladder Drainage in Malignant Biliary Stricture VideoGIE | July 2026

Introduction: Acute cholecystitis in patients with malignant biliary obstruction can be difficult to manage, particularly when surgery is not feasible. Endoscopic transpapillary gallbladder drainage (ETGBD) is an attractive minimally invasive option, but selective cannulation of...

AI for Early Esophageal Cancer Detection: AJG | July 2026

Introduction: Early detection of esophageal squamous cell carcinoma (ESCC) is critical for curative endoscopic treatment. However, subtle lesions are often missed during routine endoscopy. This meta-analysis evaluated whether deep learning (AI)-based endoscopic systems can improve...

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer